Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 10/30/2014 4:59:00 PM - Followers: 281 - Board type: Free - Posts Today: 0
NYSE now, upgraded from OTC!    

This company is 3D bioprinting. That means working towards printing human organs, using stems cells and such as ink.     


 As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. 

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit


Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.



World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 10/24/2014 05:20:50 PM
ONVO News: Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 09/30/2014 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 09/16/2014 07:01:04 PM
ONVO News: Current Report Filing (8-k) 09/15/2014 08:05:43 AM
ONVO News: Current Report Filing (8-k) 09/11/2014 08:05:00 AM
#7075  Sticky Note Ebola means money for ONVO, Here's why: Big_Money_Upward 10/13/14 12:55:37 PM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#7200   See. Shorty post is a BUY signal. dshade 10/30/14 04:59:00 PM
#7199   Good close for ONVO JMO chaostrader 10/30/14 04:31:32 PM
#7198   relive yourself of all this pain and take grantg2 10/30/14 03:50:52 PM
#7197   RUT on the verge of a new bullish heuristictrades 10/30/14 01:28:17 PM
#7196   Looks like MrMarket is expecting ZERO orders FORnextMonth. rumper 10/30/14 12:42:25 PM
#7195   must be fun living in your house. why 2014trader 10/30/14 12:28:36 PM
#7194   When is the big announcement day next month? rumper 10/30/14 12:08:32 PM
#7193   There's the buy signal/post, shorty here again!$ dshade 10/29/14 10:33:51 PM
#7192   Correct, it's troubling for this company. I mentioned adeezl 10/29/14 06:39:38 PM
#7191   lol... sounds like life grantg2 10/29/14 03:52:02 PM
#7190   Yesterday there was some pretty liberal B/A increases Homertoeclipper1 10/29/14 03:48:12 PM
#7189   ONLY A MONTH away from REVENUE, yet nothing rumper 10/29/14 03:00:56 PM
#7188   Vol slowed giving coverage time. dshade 10/29/14 02:42:26 PM
#7187   ONLY A MONTH away from REVENUE from liver grantg2 10/29/14 12:21:28 PM
#7186   that's awesome! chaostrader 10/29/14 12:17:54 PM
#7185   Organovo Only 4-6 Years Away From 3D Printing soseano 10/29/14 09:52:23 AM
#7184   Not down dshade 10/29/14 09:33:29 AM
#7183   Nice.. Over 60K up.. I imagine u have squashjohn 10/29/14 09:29:08 AM
#7182   Avg 4.15 dshade 10/29/14 09:15:13 AM
#7181   29.5K shares at ave?.. squashjohn 10/29/14 05:57:00 AM
#7180   29500 and long dshade 10/28/14 04:57:55 PM
#7179   Awesome Article - Next Month Big News is rookiecrd1 10/28/14 03:29:49 PM
#7178   Whoaa.. Thats some serious confidence in a speculative squashjohn 10/28/14 03:25:12 PM
#7177   Sold 3800shs, I'm holding 8200 from the 12K chaostrader 10/28/14 03:20:06 PM
#7176   Already out on ur trade chaos?.. I imagine squashjohn 10/28/14 03:11:49 PM
#7175   Hope everyone is having a great day with chaostrader 10/28/14 12:59:16 PM
#7174   $11.07 Aim Here. This is your Target FlashBoys! rumper 10/28/14 11:57:17 AM
#7173   Go little engine, go! Glta! stockmama22 10/28/14 11:17:12 AM
#7172   Yes they do DS! We will be on jjh573 10/28/14 10:18:20 AM
#7171   ONVO keeps moving forward. Big revenue starts next month.. dshade 10/28/14 08:22:12 AM
#7170   ONVO chart starting to look like Bitcoin early Big_Money_Upward 10/28/14 12:39:01 AM
#7169   thank you! Big_Money_Upward 10/28/14 12:05:48 AM
#7168 Penger 10/27/14 08:08:49 PM
#7167   i added 12ksh, should trade over $6 jmo chaostrader 10/27/14 01:12:34 PM
#7166   ONVO will gradually go up as usual. dshade 10/27/14 01:03:37 PM
#7165   RR, so,_the_stupid people are controlling the market? rumper 10/27/14 12:51:27 PM
#7164   Short Interest as of 10/15 rumper 10/27/14 12:15:09 PM
#7163   Organovo is too futuristic for most impatient RandolRocketman 10/27/14 11:43:57 AM
#7162   Does anyone understand why we are taking such poorman1 10/27/14 11:07:49 AM
#7161 rayank 10/24/14 10:59:36 PM
#7160   Actually breast cancer was covered at the conference dshade 10/24/14 07:58:07 PM
#7159   Hahaha you are so funny, love your approach Penger 10/24/14 06:01:00 PM
#7158   8-K out. RandolRocketman 10/24/14 05:52:07 PM
#7157   "Next month, Organovo will launch a contract research HennHouse 10/24/14 02:29:35 PM
#7156   #ebola "entirely new way to study disease" Big_Money_Upward 10/24/14 12:31:01 PM
#7155   They should've started with boobs instead of livers rumper 10/24/14 12:26:03 PM
#7154   Who are 3D Biomatrix? Are they in the 72vett 10/24/14 12:25:50 PM
#7153   Yep. ONVO has major future ahead in many areas. dshade 10/24/14 11:42:06 AM
#7152 stockmama22 10/24/14 11:05:59 AM
#7151   Longs are all up nicely and adding on dips dshade 10/24/14 10:18:32 AM